Revolutionary Skin Patch Offers Lifeline to Peanut Allergy Sufferers

A groundbreaking new treatment for peanut allergies has been developed by researchers at King's College London. The treatment, which involves a skin patch containing small amounts of peanut protein, has been shown to desensitize toddlers to peanut allergies, potentially preventing life-threatening allergic reactions. The skin patch works by gradually exposing the child to increasing amounts of peanut protein over a period of time, allowing their immune system to build up a tolerance to the allergen. In a clinical trial of 99 children with peanut allergies, the patch was found to be safe and effective, with over 80% of children responding positively to the treatment. The patch is seen as a game-changer in the treatment of peanut allergies, which can be life-threatening and severely limit the quality of life for those affected. The treatment could also potentially be extended to other food allergies, providing hope for millions of people worldwide. The researchers behind the treatment are now working to make the skin patch available to the public as soon as possible, with hopes that it could be widely available within the next few years. This breakthrough could have a profound impact on the lives of millions of people who suffer from food allergies and could pave the way for further developments in the field of immunotherapy.

Soon, People Allergic to Peanuts Can Heave a Sigh of Relief

Edwin Kim is the father of two kids, both of whom are very prone to peanut allergies. He began working on a treatment for peanut allergies when his son suffered a severe allergic reaction when he was just 9 months old. Now, Kim has developed this exciting new treatment which can help people to protect themselves from severe allergic reactions. This new treatment is called SLIT or sublingual immunotherapy. SLIT involves putting very small amounts of liquefied peanut protein under the tongue, from where it is absorbed immediately into the bloodstream to desensitize the immune system to larger amounts of peanut protein. This new treatment could enable patients to tolerate 10 to 20 times more peanut protein than it would take for them to get sick. Kim, who is a member of the UNC Children’s Research Institute said that they have long term data that shows that SLIT is safe and offers strong protection. Kim made it clear that this immunotherapy is not for kids to be able to eat peanuts or peanut butter, but to keep them safe from the small hidden exposures that could occur with packaged foods or other food exposures. According to Kim, the treatment is awaiting FDA-approval and it could be available to patients by the end of the year.